What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Disease
- Gene
Joan T. Merrill mainly focuses on Internal medicine, Lupus erythematosus, Immunology, Placebo and Connective tissue disease.
Her studies in Internal medicine integrate themes in fields like Gastroenterology and Surgery.
Joan T. Merrill has researched Lupus erythematosus in several fields, including Systemic lupus erythematosus, Randomized controlled trial, Human leukocyte antigen and Cohort.
Her Immunology study combines topics in areas such as Genotype, Single-nucleotide polymorphism and Haplotype.
Her research in Placebo intersects with topics in Belimumab and Adverse effect, Pharmacology.
Her Connective tissue disease research incorporates elements of Systemic disease, Immunopathology and Quality of life.
Her most cited work include:
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. (2280 citations)
- Human polymorphism at microRNAs and microRNA target sites. (1284 citations)
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. (1069 citations)
What are the main themes of her work throughout her whole career to date?
Joan T. Merrill mainly investigates Internal medicine, Immunology, Systemic lupus erythematosus, Lupus erythematosus and Rheumatology.
The various areas that Joan T. Merrill examines in her Internal medicine study include Gastroenterology and Placebo.
She regularly ties together related areas like Disease in her Immunology studies.
Her Systemic lupus erythematosus study deals with Cohort intersecting with Cohort study.
Her research investigates the connection between Lupus erythematosus and topics such as Connective tissue disease that intersect with issues in Immunopathology.
Her Rheumatology research is multidisciplinary, relying on both Quality of life, Systemic lupus, Physical therapy, Pediatrics and INCEPTION COHORT.
She most often published in these fields:
- Internal medicine (52.77%)
- Immunology (48.69%)
- Systemic lupus erythematosus (39.36%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (52.77%)
- Systemic lupus erythematosus (39.36%)
- Lupus erythematosus (25.66%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Internal medicine, Systemic lupus erythematosus, Lupus erythematosus, Clinical trial and Placebo.
In her research, Joan T. Merrill performs multidisciplinary study on Internal medicine and In patient.
Joan T. Merrill interconnects Disease severity, Anti-nuclear antibody, Quality of life, Immune system and Abatacept in the investigation of issues within Systemic lupus erythematosus.
Her study in Lupus erythematosus is interdisciplinary in nature, drawing from both Young adult, Pregnancy, Physical therapy and Severity of illness.
Her Placebo study also includes fields such as
- Arthritis which connect with Rash and Gastroenterology,
- Randomization which connect with Phases of clinical research.
Her biological study spans a wide range of topics, including Antibody and Immunology.
Between 2017 and 2021, her most popular works were:
- Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. (66 citations)
- Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial (43 citations)
- Lupus community panel proposals for optimising clinical trials: 2018 (31 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Internal medicine, Lupus erythematosus, Systemic lupus erythematosus, Young adult and Clinical trial are her primary areas of study.
Her Internal medicine study frequently draws connections to other fields, such as Placebo.
Her studies deal with areas such as Odds ratio, Pregnancy, Predictive value of tests and Severity of illness as well as Lupus erythematosus.
In her research, Complex disease, Physical therapy and Systemic therapy is intimately related to Disease activity, which falls under the overarching field of Systemic lupus erythematosus.
Her work deals with themes such as Polypharmacy, Intensive care medicine and Adverse effect, which intersect with Clinical trial.
Her Transcriptome research includes themes of Plasma cell and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
